PEP-19 (Purkinje cell protein 4) is an intrinsically disordered protein with an IQ calmodulin (CaM) binding motif. Expression of PEP-19 was recently shown to protect cells from apoptosis and cell death due to Ca 2+ overload. Our initial studies showed that PEP-19 causes novel and dramatic increases in the rates of Ca 2+ association and dissociation from the C-domain of CaM. The goal of this work was to study interactions between C-domain of CaM (C-CaM) and PEP-19 by solution NMR to identify mechanisms by which PEP-19 regulates Ca 2+ binding to CaM. Our results show that PEP-19 causes a greater structural change in apo C-CaM relative to Ca 2+ -CCaM, and that the 1 st Ca 2+ binds preferentially to site IV in the presence of PEP-19 with exchange characteristics that are consistent with a decrease in Ca 2+ binding cooperativity. Relatively weak binding of PEP-19 has distinct effects on chemical/conformational exchange on the μs-ms timescale. In apo C-CaM, PEP-19 binding causes a redistribution of residues that experience conformational exchange, leading to an increase in residues around Ca 2+ binding site IV that undergo conformational exchange on μs-ms timescale. This appears to be due to an allosteric effect since these residues are not localized to the PEP-19 binding site. In contrast, PEP-19 increases the number of residues that exhibit conformational exchange in Ca 2+ -C-CaM. These residues are primarily localized to the PEP-19 binding site, but also include Asp93 in site III. These results provide working models for the role of protein dynamics in regulation of Ca 2+ binding to CaM by PEP-19 (Purkinje cell protein 4) is a small 6.7 kDa polypeptide that was initially identified in the central nervous system (CNS), but is now known to be present in a variety of other tissues (for review see (1-5)). PEP-19 has no known intrinsic activity other than binding to calmodulin (CaM) in the presence or absence of Ca 2+ via an IQ CaM binding motif. This gives PEP-19 the potential to exert broad cellular effects as a regulator of CaM signaling. This idea is consistent with a general cytoprotective role for PEP-19 put forth based on the fact that Purkinje cells of the cerebellum and granule-cell neurons in the dentate gyrus, which have high levels of PEP-19, are largely spared from the effects of Alzheimer's Disease, while PEP-19 negative cells are severely affected (6). Conversely, cell types that are most affected by Huntington's disease exhibit a significant loss of expression of PEP-19 (7). Experimental studies also support a cytoprotective role for PEP-19 since expression of PEP-19 greatly inhibits cell death due to apoptosis (8,9), or glutamate-induced Ca 2+ cytotoxicity (9). Interestingly, PEP-19 is greatly increased in human leiomyoma versus matched myometrium (10), and high levels of PEP-19 are found in 58 of 60 NCI-60 tumor cell lines (11), even cells derived from tissues that express low or no PEP-19. This may be related to increased survival potential of transformed cells due to antiapoptotic effects of...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.